Table 2 Prevalence of components of undiagnosed metabolic syndrome among apparently healthy individuals living in Karachi, Pakistan in the year 2022
| Â | IDF | NCEP ATP III | Modified NCEP-ATP III |
|---|---|---|---|
Metabolic Abnormalities | % (95% CI) | % (95% CI) | % (95% CI) |
Central Obesity | 73.9 (71.1–76.5) | 38.9 (35.9–41.8) | 73.9 (71.1–76.5) |
Elevated Fasting Plasma Glucose | 19.5 (17.1–22.0) | 11.6 (9.7–13.7) | 19.5 (17.1–22.0) |
Elevated Triglyceride | 19.6 (17.2–22.1) | 19.6 (17.2–22.1) | 19.6 (17.2–22.1) |
Reduced HDL | 49.9 (46.8–52.9) | 49.9 (46.8–52.9) | 49.9 (46.8–52.9) |
High Blood Pressure | 51.1 (48.0-54.1) | 51.1 (48.0-54.1) | 51.1 (48.0-54.1) |
Metabolic Syndrome | 32.2 (29.0–35.0) | 22.4 (19.0–25.0) | 33.9 (31.0–36.0) |